clinical trials

ASCO25: Merck KGaA’s ADC shows safety and tolerability in colorectal cancer trial
Clinical Trials Arena
Fri, 05/30/25 - 11:28 am
Merck KGaA
precemtabart tocentecan
clinical trials
ASCO 2025
ASCO: Pfizer, chasing full approval conversion for Braftovi combo, touts 'unprecedented' survival win
Fierce Pharma
Fri, 05/30/25 - 11:25 am
ASCO 2025
Pfizer
Braftovi
clinical trials
metastatic colorectal cancer
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
BioPharma Dive
Fri, 05/30/25 - 11:23 am
Regeneron
Sanofi
COPD
clinical trials
itepekimab
Intellia's stock sinks on gene therapy patient's raised enzyme levels, but analysts keep faith
Fierce Biotech
Thu, 05/29/25 - 11:11 am
Intellia Therapeutics
clinical trials
gene therapy
nex-z
transthyretin amyloid cardiomyopathy
China's biotech boom leaves U.S. playing catch-up
Axios
Thu, 05/29/25 - 10:41 am
China
clinical trials
R&D
biotech
Merck KGaA to seek approval of TGCT drug after Phase III success
Clinical Trials Arena
Thu, 05/29/25 - 10:37 am
ASCO 2025
Merck KGaA
pimicotinib
clinical trials
tenosynovial giant cell tumors
Scynexis says GSK on hook for $10M payment after phase 3 Brexafemme trial starts back up
Fierce Pharma
Wed, 05/28/25 - 11:04 pm
GSK
Scynexis
Brexafemme
clinical trials
antifungals
Muscle-sparing obesity drug safe for Phase 3 trial, Veru says
BioPharma Dive
Wed, 05/28/25 - 10:58 pm
Veru
obesity
endobosarm
Novo Nordisk
Wegovy
clinical trials
PepGen ends all work on Duchenne muscular dystrophy after lead asset fails to raise dystrophin levels
Fierce Biotech
Wed, 05/28/25 - 10:56 pm
PepGen
DMD
clinical trials
Duchenne Muscular Dystrophy
PGN-EDO51
Mapping out opportunities to reduce emissions in clinical trials
Clinical Trials Arena
Wed, 05/28/25 - 10:55 am
Genentech
clinical trials
sustainability
GSK's $66M bet on Spero's rejected UTI antibiotic pays off with a phase 3 win
Fierce Biotech
Wed, 05/28/25 - 09:46 am
GSK
Spero Therapeutics
antibiotics
UTIs
tebipenem
clinical trials
Merck KGaA shares phase 3 rare tumor data ahead of showdown with Daiichi and Ono
Fierce Biotech
Wed, 05/28/25 - 09:39 am
Merck KGaA
clinical trials
tenosynovial giant cell tumors
pimicotinib
Daiichi Sankyo
Ono Pharmaceutical
BrainStorm Cell Therapeutics and Minaris partner on manufacturing NurOwn for trial
Clinical Trials Arena
Wed, 05/28/25 - 09:37 am
BrainStorm Cell Therapeutics
Minaris
NurOwn
clinical trials
Gilgamesh links psychedelic to 94% remission rate in midphase depression trial
Fierce Biotech
Tue, 05/27/25 - 10:13 pm
Gilgamesh Pharmaceuticals
clinical trials
psychedelic drugs
depression
GM-2505
Gilead Sciences (GILD) announces positive data from Phase 3 Trodelvy study
Street Insider
Fri, 05/23/25 - 08:45 am
Gilead Sciences
Trodelvy
clinical trials
triple negative breast cancer
Astellas and Pfizer’s Xtandi combo reduces death risk in prostate cancer trial
Clinical Trials Arena
Fri, 05/23/25 - 08:31 am
Astellas
Pfizer
clinical trials
Xtandi
metastatic hormone-sensitive prostate cancer
prostate cancer
AnnJi reports outcomes from trial of spinal bulbar muscular atrophy therapy
Clinical Trials Arena
Thu, 05/22/25 - 11:22 am
Annji Pharmaceutical
clinical trials
AJ201
SBMA
Auxilium Enrolls First Patient in NeuroSpan Bridge Trial for Nerve Regeneration
Medical Devices and Diagnostics Industry
Thu, 05/22/25 - 11:04 am
Auxilium
NeuroSpan Bridge
clinical trials
Medtech
nerve regeneration
Merck KGaA shares data justifying pushing lupus drug into phase 3—despite recent setback
Fierce Biotech
Wed, 05/21/25 - 10:21 pm
Merck
KGaA
lupus
clinical trials
enpatoran
Diversity commitment persists in clinical trials amidst policy shifts
Clinical Trials Arena
Tue, 05/20/25 - 09:47 pm
diversity
clinical trials

Pages